Intensity Therapeutics, Inc. (INTS)

Intensity Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
2,222,223
Deal Size
$10.00M

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20202019
Selling, General & Admin
1.171.24
Research & Development
5.054.44
Operating Expenses
6.225.68
Operating Income
-6.22-5.68
Interest Expense / Income
-0.07-0.15
Other Expense / Income
-0.12-0.14
Pretax Income
-6.03-5.38
Net Income
-6.03-5.38
Net Income Common
-6.03-5.38
EBITDA
-6.1-5.53
EBIT
-6.1-5.53
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).